NZ242493A - Quinoline derivatives and pharmaceutical compositions - Google Patents
Quinoline derivatives and pharmaceutical compositionsInfo
- Publication number
- NZ242493A NZ242493A NZ242493A NZ24249392A NZ242493A NZ 242493 A NZ242493 A NZ 242493A NZ 242493 A NZ242493 A NZ 242493A NZ 24249392 A NZ24249392 A NZ 24249392A NZ 242493 A NZ242493 A NZ 242493A
- Authority
- NZ
- New Zealand
- Prior art keywords
- ureido
- bis
- chlorophenyl
- methylthio
- quinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69232391A | 1991-04-26 | 1991-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ242493A true NZ242493A (en) | 1994-08-26 |
Family
ID=24780107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ242493A NZ242493A (en) | 1991-04-26 | 1992-04-24 | Quinoline derivatives and pharmaceutical compositions |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0590094A1 (pt) |
| JP (1) | JPH0776215B2 (pt) |
| CN (1) | CN1066068A (pt) |
| AU (1) | AU1879792A (pt) |
| BR (1) | BR9205939A (pt) |
| CA (1) | CA2108014A1 (pt) |
| CZ (1) | CZ395592A3 (pt) |
| DE (1) | DE9290049U1 (pt) |
| FI (1) | FI934710A0 (pt) |
| HU (1) | HUT65748A (pt) |
| IE (1) | IE921330A1 (pt) |
| IL (1) | IL101627A0 (pt) |
| MX (1) | MX9201916A (pt) |
| NO (1) | NO933837L (pt) |
| NZ (1) | NZ242493A (pt) |
| PT (1) | PT100426A (pt) |
| TW (1) | TW197436B (pt) |
| WO (1) | WO1992019614A1 (pt) |
| YU (1) | YU44592A (pt) |
| ZA (1) | ZA922976B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3323393A (en) * | 1992-01-23 | 1993-09-01 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| US5565472A (en) * | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| NZ264063A (en) * | 1993-08-13 | 1995-11-27 | Nihon Nohyaku Co Ltd | N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions |
| US5843957A (en) * | 1995-05-19 | 1998-12-01 | Sumitomo Pharmaceuticals Company, Ltd. | Naphthyridine derivatives |
| NZ308228A (en) * | 1995-05-31 | 1999-11-29 | Sumitomo Pharma | Substituted 1,8-naphthyridine derivatives |
| KR20000057268A (ko) * | 1996-11-26 | 2000-09-15 | 다께우찌 마사야쓰 | 나프티리딘 유도체 |
| US6452008B2 (en) | 1998-02-25 | 2002-09-17 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for preparing the same |
| AU2547399A (en) | 1998-02-25 | 1999-09-15 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for producing the same |
| KR20070001922A (ko) * | 2003-12-12 | 2007-01-04 | 와이어쓰 | 심장혈관질환 치료에 유용한 퀴놀린 |
| CN103601677B (zh) * | 2013-11-19 | 2015-11-18 | 清华大学 | 制备2-烷硫基喹啉衍生物的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE892088L (en) * | 1988-07-12 | 1990-01-12 | William Henry Deryk Morris | Quinoline derivatives, their production and use |
| MX22406A (es) * | 1989-09-15 | 1994-01-31 | Pfizer | Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat). |
| TW205037B (pt) * | 1989-10-06 | 1993-05-01 | Takeda Pharm Industry Co Ltd |
-
1992
- 1992-03-16 AU AU18797/92A patent/AU1879792A/en not_active Abandoned
- 1992-03-16 HU HU9303025A patent/HUT65748A/hu active IP Right Revival
- 1992-03-16 WO PCT/US1992/001801 patent/WO1992019614A1/en not_active Application Discontinuation
- 1992-03-16 CA CA002108014A patent/CA2108014A1/en not_active Abandoned
- 1992-03-16 EP EP92923349A patent/EP0590094A1/en not_active Withdrawn
- 1992-03-16 JP JP4510186A patent/JPH0776215B2/ja not_active Expired - Lifetime
- 1992-03-16 DE DE9290049U patent/DE9290049U1/de not_active Expired - Lifetime
- 1992-03-16 CZ CS923955A patent/CZ395592A3/cs unknown
- 1992-03-16 BR BR9205939A patent/BR9205939A/pt not_active Application Discontinuation
- 1992-03-17 TW TW081102005A patent/TW197436B/zh active
- 1992-03-24 ZA ZA922976A patent/ZA922976B/xx unknown
- 1992-04-16 IL IL101627A patent/IL101627A0/xx unknown
- 1992-04-24 YU YU44592A patent/YU44592A/sh unknown
- 1992-04-24 IE IE133092A patent/IE921330A1/en not_active Application Discontinuation
- 1992-04-24 NZ NZ242493A patent/NZ242493A/en unknown
- 1992-04-24 PT PT100426A patent/PT100426A/pt not_active Application Discontinuation
- 1992-04-24 MX MX9201916A patent/MX9201916A/es not_active IP Right Cessation
- 1992-04-25 CN CN92103010A patent/CN1066068A/zh active Pending
-
1993
- 1993-10-25 FI FI934710A patent/FI934710A0/fi unknown
- 1993-10-25 NO NO933837A patent/NO933837L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI934710A (fi) | 1993-10-25 |
| CA2108014A1 (en) | 1992-10-27 |
| CN1066068A (zh) | 1992-11-11 |
| BR9205939A (pt) | 1994-09-27 |
| AU1879792A (en) | 1992-12-21 |
| WO1992019614A1 (en) | 1992-11-12 |
| IE921330A1 (en) | 1992-11-04 |
| ZA922976B (en) | 1993-10-25 |
| HU9303025D0 (en) | 1994-01-28 |
| YU44592A (sh) | 1994-12-28 |
| FI934710A0 (fi) | 1993-10-25 |
| CZ395592A3 (en) | 1994-02-16 |
| EP0590094A1 (en) | 1994-04-06 |
| MX9201916A (es) | 1992-11-01 |
| IL101627A0 (en) | 1992-12-30 |
| HUT65748A (en) | 1994-07-28 |
| DE9290049U1 (de) | 1994-01-05 |
| PT100426A (pt) | 1993-08-31 |
| JPH06501025A (ja) | 1994-01-27 |
| JPH0776215B2 (ja) | 1995-08-16 |
| TW197436B (pt) | 1993-01-01 |
| NO933837L (no) | 1993-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5596001A (en) | 4-aryl-3-(heteroarylureido)quinoline derivatves | |
| CA2188164C (en) | Benzamide compounds and pharmaceutical use thereof | |
| AU681075B2 (en) | Antiproliferative quinazolines | |
| RU2256662C2 (ru) | Бициклические азотсодержащие гетероциклы и содержащая их фармацевтическая композиция | |
| EP1254138B1 (en) | Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase | |
| EP1121355B1 (en) | Quinoline derivatives and their use as antibacterial agents | |
| US6335341B1 (en) | Pyridyl-and pyrimidyl-heterocyclic compounds inhibiting oxido squalene-cyclase | |
| EP0088593B1 (en) | 1,2,4-triazine and pyrazine derivatives | |
| US5063227A (en) | Quinazoline-substituted pyridazinone derivatives having cardiotonic activity | |
| EP0642498A1 (en) | NEW $i(N)-ARYL AND $i(N)-HETEROARYLUREA DERIVATIVES AS INHIBITORS OF ACYL COENZYME A:CHOLESTEROL ACYL TRANSFERASE (ACAT) | |
| US5565472A (en) | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents | |
| NZ242493A (en) | Quinoline derivatives and pharmaceutical compositions | |
| CA2128093C (en) | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents | |
| US7713972B2 (en) | Imidazotriazinone derivatives as PDE 7 (phosphodiesterase 7) inhibitors | |
| JPS6024794B2 (ja) | オキサジアゾロピリミジン誘導体 | |
| CA2179735A1 (en) | N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs | |
| US20030073691A1 (en) | Polycyclic compounds | |
| EP0218423B1 (en) | 9-(Substituted thio)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives, their manufacture and use | |
| CA2260057A1 (en) | Novel compounds | |
| AU2002342752A1 (en) | Polycyclic compounds having anti-tumor activity | |
| JP2961891B2 (ja) | ベンズアミド化合物およびその医薬用途 | |
| WO1994002469A1 (en) | Pyrimidine compounds used in the therapy | |
| US5484924A (en) | Imidazonaphthyridine derivatives | |
| JPH0259571A (ja) | ピリドン誘導体又はその塩類 | |
| JPH10120644A (ja) | ２−ウレイド−ベンズアミド誘導体 |